Track topics on Twitter Track topics that are important to you
How to create a sustainable global UDI compliance strategy to future-proof your systems and processes.
SANTA BARBARA, Calif. (PRWEB) April 17, 2019
USDM Life Sciences (USDM) announces that Jay Crowley, Vice President of UDI Services and Solutions at USDM, will deliver a presentation on solutions for Creating a Sustainable Global UDI Compliance Strategy at the European UDI Forum on 25 April 2019.
Jay’s presentation will include the following insights:
What: Creating a Sustainable Global UDI Compliance Strategy
Where: European UDI Forum — Pullman Brussels Centre Midi Hotel — Brussels, Belgium
When: 25 April 2019 at 10:20AM
“EUDAMED database compliance requirements under the European Medical Devices Regulation (MDR) and In-vitro Diagnostics Regulation (IVDR) are coming, and medical device manufacturers need to be building their global compliance strategy now,” said Jay Crowley. “Companies that successfully build a compliance strategy to future-proof their data management processes will stay ahead of any new regulatory requirements that arise.”
Jay is a recognized expert in the area of UDI and held a variety of positions over his 26 years at the FDA, including developing the framework and authoring key requirements for the FDA’s UDI system. Most recently Jay was the Senior Advisor for Patient Safety in the FDA’s Center for Devices and Radiological Health. His contributions to design control regulations to reduce the chance of human errors with medical devices, patient safety, and adverse event reporting are highly regarded.
The European UDI Forums 24-25 April 2019 in Brussels, Belgium.
About USDM Life Sciences:
USDM Life Sciences provides strategy and compliant technology solutions to regulated life sciences companies and makes it easy to accelerate transformation and innovation. USDM Life Sciences focuses exclusively on the regulated biotechnology, pharmaceutical, and medical device industries and is a compliance partner with the world’s top technology software developers. For more information, visit http://www.usdm.com
USDM Life Sciences
For the original version on PRWeb visit: https://www.prweb.com/releases/jay_crowley_to_present_solutions_for_global_udi_compliance_at_the_european_udi_forum_in_brussels/prweb16245894.htmNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...